 differences in perioperative and 1year outcomes between CEA vs restenting or PTA. However, CEA was offered to patients who are more severely
ill than redo CAS, resulting in signiﬁcantly higher mortality (3.7% vs 0.9%; P ¼ .02).473
Summary and recommendations for treatment of
restenosis following CAS.
1. Most asymptomatic patients (>70% restenosis)
should be treated with aggressive